Headquartered in Cambridge, UK, Qureight’s data and AI-analytics platform accelerates drug development in lung and heart diseases. It houses a cloud-based, vendor-agnostic platform which holds ISO 13485 and ISO 27001 accreditation. The team is led by co-founder & CEO Dr Muhunthan Thillai, a pulmonologist specialising in complex lung diseases.